Global COVID-19 vaccine inequity: The scope, the impact, and the challenges
- PMID: 34265241
- PMCID: PMC8279498
- DOI: 10.1016/j.chom.2021.06.007
Global COVID-19 vaccine inequity: The scope, the impact, and the challenges
Abstract
Global vaccine inequity is prolonging the COVID-19 pandemic. Here, we outline the scope and impact of inequitable vaccine distribution and identify challenges in vaccine development, manufacturing, and distribution as well as potential solutions to address this crisis.
Copyright © 2021 Elsevier Inc. All rights reserved.
References
-
- Cohen J., Kupferschmidt K. Rich countries cornered COVID-19 vaccine doses. Four strategies to right a ‘scandalous inequity. Science. 2021 doi: 10.1126/science.abj6604. - DOI
-
- Evenett S.J. Brookings Insitute; 2021. How big of a vaccine surplus will the US have?
-
- Gennari A., Holt T., Jordi E., Kaplow L. McKinsey Insights: McKinsey & Co.; 2021. Africa needs vaccines. What would it take to make them here? p. 12.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
